Israel ' s Gamida Cell Raises $40 Mln for Bone Marrow Trial Israel ' s Gamida Cell Raises $40 Mln for Bone Marrow Trial

Israel ' s Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Transplantation News Source Type: news